161 related articles for article (PubMed ID: 9718289)
21. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
Goff DC; Tsai G; Manoach DS; Coyle JT
Am J Psychiatry; 1995 Aug; 152(8):1213-5. PubMed ID: 7625475
[TBL] [Abstract][Full Text] [Related]
22. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
23. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion.
Pu S; Xu B; Kalra SP; Kalra PS
Endocrinology; 1996 May; 137(5):1949-55. PubMed ID: 8612535
[TBL] [Abstract][Full Text] [Related]
24. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.
D'Souza DC; Gil R; Cassello K; Morrissey K; Abi-Saab D; White J; Sturwold R; Bennett A; Karper LP; Zuzarte E; Charney DS; Krystal JH
Biol Psychiatry; 2000 Mar; 47(5):450-62. PubMed ID: 10704956
[TBL] [Abstract][Full Text] [Related]
25. D-alanine added to antipsychotics for the treatment of schizophrenia.
Tsai GE; Yang P; Chang YC; Chong MY
Biol Psychiatry; 2006 Feb; 59(3):230-4. PubMed ID: 16154544
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers.
von Bahr C; Wiesel FA; Movin G; Eneroth P; Jansson P; Nilsson L; Ogenstad S
Psychopharmacology (Berl); 1991; 103(4):443-8. PubMed ID: 1676524
[TBL] [Abstract][Full Text] [Related]
27. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.
Hood WF; Compton RP; Monahan JB
Neurosci Lett; 1989 Mar; 98(1):91-5. PubMed ID: 2540460
[TBL] [Abstract][Full Text] [Related]
28. Differences in the luteinizing hormone and prolactin responses to multiple injections of kainate, as compared to N-methyl-D,L-aspartate, in cycling rats.
Abbud R; Smith MS
Endocrinology; 1991 Dec; 129(6):3254-8. PubMed ID: 1659525
[TBL] [Abstract][Full Text] [Related]
29. The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans.
Nottage JF; Gabay A; De Meyer K; Herrik KF; Bastlund JF; Christensen SR; Gijsen S; Mehta MA
Psychopharmacology (Berl); 2023 Jan; 240(1):59-75. PubMed ID: 36401646
[TBL] [Abstract][Full Text] [Related]
30. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
[TBL] [Abstract][Full Text] [Related]
31. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.
Heresco-Levy U; Kremer I; Javitt DC; Goichman R; Reshef A; Blanaru M; Cohen T
Int J Neuropsychopharmacol; 2002 Dec; 5(4):301-7. PubMed ID: 12466030
[TBL] [Abstract][Full Text] [Related]
32. Photoperiodic regulation of glutamatergic stimulation of secretion of luteinizing hormone in male Syrian hamsters.
Hui Y; Hastings MH; Maywood ES; Ebling FJ
J Reprod Fertil; 1992 Aug; 95(3):935-46. PubMed ID: 1357168
[TBL] [Abstract][Full Text] [Related]
33. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
Matsuoka N; Aigner TG
J Pharmacol Exp Ther; 1996 Aug; 278(2):891-7. PubMed ID: 8768744
[TBL] [Abstract][Full Text] [Related]
34. The glycine/NMDA receptor ligand (+)-HA-966 but not D-cycloserine has potent antidystonic efficacy in a genetic animal model of dystonia.
Löscher W; Richter A
Eur J Pharmacol; 1993 Aug; 239(1-3):245-7. PubMed ID: 8223902
[TBL] [Abstract][Full Text] [Related]
35. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.
Breier A; Davis OR; Buchanan RW; Moricle LA; Munson RC
Arch Gen Psychiatry; 1993 Jul; 50(7):541-50. PubMed ID: 8317948
[TBL] [Abstract][Full Text] [Related]
36. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
Carlsson ML; Engberg G; Carlsson A
J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
[TBL] [Abstract][Full Text] [Related]
37. Effects of NMDA modulation in scopolamine dementia.
Jones RW; Wesnes KA; Kirby J
Ann N Y Acad Sci; 1991; 640():241-4. PubMed ID: 1837979
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release.
D'Aniello A; Di Fiore MM; Fisher GH; Milone A; Seleni A; D'Aniello S; Perna AF; Ingrosso D
FASEB J; 2000 Apr; 14(5):699-714. PubMed ID: 10744627
[TBL] [Abstract][Full Text] [Related]
39. Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study.
Takiguchi K; Uezato A; Itasaka M; Atsuta H; Narushima K; Yamamoto N; Kurumaji A; Tomita M; Oshima K; Shoda K; Tamaru M; Nakataki M; Okazaki M; Ishiwata S; Ishiwata Y; Yasuhara M; Arima K; Ohmori T; Nishikawa T
BMC Psychiatry; 2017 Jul; 17(1):249. PubMed ID: 28701225
[TBL] [Abstract][Full Text] [Related]
40. N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat.
Farah JM; Rao TS; Mick SJ; Coyne KE; Iyengar S
Endocrinology; 1991 Apr; 128(4):1875-80. PubMed ID: 1848504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
